We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04318730
Brief Title: Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical Carcinoma
First Submitted : March 20, 2020
First Submitted that Met QC Criteria : March 20, 2020
First Posted : March 24, 2020
Last Update Submitted that Met QC Criteria : December 16, 2022
Last Update Posted : December 19, 2022